$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
The overall goal is to obtain quantitative evidence in time and space of receptor colocalization with specific subcellular organelles after treatment with a receptor agonist. Thus, the immediate goal here is to capture time-lapse confocal images of lysosomes and a transmembrane spanning receptor in human embryonic kidney cells (HEK) following transfection and to subsequently assemble and analyze the imaging data in 3D to quantitatively measure the delivery of receptor to lysosomes. Investigating the simultaneous trafficking of a transmembrane receptor with lysosomes or other organelles during endocytosis when activated by receptor ligand can help determine how the transmembrane receptor is regulated under physiological and pathophysiological conditions.
AT1aR is presumed to be degraded in lysosomes following treatment with Ang II in model cells systems, primarily HEK293 1 although the majority of receptors are primarily localized in multivesicular recycling endosomes for later recycling to the plasma membrane while the bulk of the ligand, Ang II, is degraded in the lysosome 2,3,4,5. More recently, Li et al. demonstrated using Förster resonance energy transfer (FRET) and fluorescence lifetime imaging microscopy (FLIM) techniques that AT1aR colocalizes (on ~10 nm scale) with LAMP1, a lysosomal membrane protein suggesting that at least some of the receptor is targeted to and degraded by lysosomes 6. These authors noted that the lysosomal inhibitor chloroquine blocked AT1aR-LAMP1 association which is consistent with previous reports suggesting that an effect of chloroquine is to block fusion of late endosomes or autophagosomes with lysosomes. Other indirect approaches to determine AT1aR localization in lysosomes have utilized bafilomycin, a lysosomal inhibitor to infer AT1aR presence in lysosomes 3,4,5,6,7,8.
Live-cell imaging avoids potential effects of fixation on cell volume, and loss/dimming/redistribution of GFP-chimeric receptor. Previous studies have relied upon fixed cells to determine colocalization or co-occurrence of the receptor with lysosomes or using live cells labeled with receptor-binding surrogates such as β-arrestin 1,2,3,4,5,6. Live-cell imaging of other GPCRs using spinning disk confocal or laser point scanning confocal microscopes equipped with GaASP or HyD detectors enabled investigators to observe the internalization and trafficking of receptors in individual cells imaged in z-stacks at 30 s intervals 9,10. However even when live cell z-stacks are rapidly collected, analysis may only occur after selection of a single plane within each stack, i.e. in 2D 10. While this might be sufficient for studying the internalized GPCR or tyrosine kinase receptor in question, the AT1aRs accumulates in vesicles that change size and position over time and thus are inherently more difficult to adequately sample using a representative single slice at each time point. To thoroughly determine the route of the labeled AT1aR through the cell and to detect each subpopulation of vesicles differing in size and position, we have devised a method for 3D imaging and 3D analysis to track these changes and to be used in conjunction with labeling of various intracellular compartments such as lysosomes.
Investigators can use this protocol for live-cell imaging to directly visualize the movement of AT1aR into the cell and its transfer to subcellular compartments following Ang II stimulation. Subcellular compartments are tagged with fluorescent protein chimeras or other fluorescent markers. This protocol can also be used as a first approach to localize receptors in subcellular organelles with a minimum resolution of 200 nm in order to compare mutated versus wild-type receptors or to detect changes following pharmacological treatments. The technique is accessible since it can be carried out on any confocal microscope equipped for live-cell imaging. The relative ease of this approach contrasts with increased expertise and equipment needed to carry out FRET/FLIM/BRET techniques which detect molecular interactions 6,11. These measurements define protein-protein interactions at high resolution (~10 nm) and localization within subcellular organelles is inferred. These more advanced techniques are used to follow up and further define molecular interactions of interest, rather than the passage of receptors through subcellular compartments, and they directly demonstrate protein-protein interactions at specific times and places within the cell 11. FLIM, a FRET technique independent of acceptor concentration, is most often performed on fixed samples since image acquisition is slower. In contrast, ratio FRET provides rapid imaging and high resolution colocalization of interacting proteins. The disadvantage of ratio FRET is that imaging utilizes widefield epi-fluorescence to gain imaging speed and to include the entire cell, resulting in reduced resolution and contrast of organelles 12. Bioluminescence resonance energy transfer (BRET) is another advanced technique that has been applied to GPCRs to measure the acquisition of molecular proximity over time 11. In this technique a protein fluorophore is molecularly divided and each half linked to one of two proteins in question. When the two proteins of interest bind each other, the parts of the chimeric tag re-assemble to acquire fluorescence and the increased fluorescence quantified over time.
Here, we present a straightforward technique for live-cell imaging coupled with image quantification to study trafficking of AT1aR in the cell upon Ang II stimulation and the potential change in delivery of internalized AT1aR to lysosomes following Ang II stimulation. The ultimate use for this technique is to characterize differences in membrane trafficking comparing wild type and mutated receptors. These differences will help to identify the mechanism(s) that impact physiological activities of AT1aR leading to regulation of blood pressure.